Search research articles
Contact Us
Filters
Showing results (1401-1410 of 1,601) with videos related to
Page
of 161
Sort By:
Blood
|
August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
Till Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
Journal of Consulting and Clinical Psychology
|
December 21, 2018
Trajectories and predictors of response in youth anxiety CBT: Integrative data analysis
Laura C Skriner, Brian C Chu, Mehmet Kaplan, et al.
Tissue Antigens
|
October 2, 2012
The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study
C-Y Huang, T-Y Chang, C-C Chu, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Rapamycin Reduces Arterial Mineral Density and Promotes Beneficial Vascular Remodeling in a Murine Model of Severe Medial Arterial Calcification
Parya Behzadi, Rolando A Cuevas, Alex Crane, et al.
Leukemia Research
|
April 1, 2023
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions
Jeremiah E Moore, Paige C Bloom, Charles C Chu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 2, 2012
Predictors for cognitive decline in patients with confluent white matter hyperintensities
Vincent Mok, Yunyun Xiong, Kelvin K Wong, et al.
BMC Public Health
|
August 28, 2023
Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States
Brooke G Rogers, P A Chan, C Sutten-Coats, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma
Terence K Lee, Kwan Man, Joanna W Ho, et al.
BMC Infectious Diseases
|
August 5, 2022
Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States
Brooke G Rogers, C Sosnowy, A Zanowick-Marr, et al.
British Journal of Cancer
|
September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
A C Mita, K Papadopoulos, M J A de Jonge, et al.
Page
of 161
Search research articles
Search
Showing results (1401-1410 of 1,601) with videos related to
Sort By:
Page
of 161
Blood
|
August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
Till Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
Journal of Consulting and Clinical Psychology
|
December 21, 2018
Trajectories and predictors of response in youth anxiety CBT: Integrative data analysis
Laura C Skriner, Brian C Chu, Mehmet Kaplan, et al.
Tissue Antigens
|
October 2, 2012
The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study
C-Y Huang, T-Y Chang, C-C Chu, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Rapamycin Reduces Arterial Mineral Density and Promotes Beneficial Vascular Remodeling in a Murine Model of Severe Medial Arterial Calcification
Parya Behzadi, Rolando A Cuevas, Alex Crane, et al.
Leukemia Research
|
April 1, 2023
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions
Jeremiah E Moore, Paige C Bloom, Charles C Chu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 2, 2012
Predictors for cognitive decline in patients with confluent white matter hyperintensities
Vincent Mok, Yunyun Xiong, Kelvin K Wong, et al.
BMC Public Health
|
August 28, 2023
Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States
Brooke G Rogers, P A Chan, C Sutten-Coats, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma
Terence K Lee, Kwan Man, Joanna W Ho, et al.
BMC Infectious Diseases
|
August 5, 2022
Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States
Brooke G Rogers, C Sosnowy, A Zanowick-Marr, et al.
British Journal of Cancer
|
September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
A C Mita, K Papadopoulos, M J A de Jonge, et al.
Page
of 161